CONATUS PHARMACEUTICALS INC

Visual Financials
Company Name: Conatus Pharmaceuticals Inc
Ticker Symbol: CNAT
CIK Number: 0001383701
WWW Address:
CEO: Dr. Steven J. Mento,PhD
No. of Employees: 0
Common Issue Type:
Business Description:

 
Industry Information: - [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 0.328 Up 0.0096 0.3269 0.3299 0.3198 0.80 0.73 581851
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 10.9 33.2 0.00 -0.59 0.00 0.0 0.0 6.74 - 0.69
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close0.73$
PE Ratio - LTM0.0
Market Capitalisation10.9mil
Latest Shares Outstanding33.2mil
Earnings pS (EPS)-0.59$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee1,083,419$
Effective Tax Rate0.0%
Float31.4mil
Float as % of Shares Outstanding0.9%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue1.20%
Gross Profit Margin0.0%
EBITDA Margin-51.3%
Pre-Tax Profit Margin0.0%
Assets Turnover51.4%
Return on Assets (ROA)-27.6%
Return on Equity (ROE)-65.0%
Return on Capital Invested (ROCI)-66.0%
Current Ratio2.6
Leverage Ratio (Assets/Equity)1.8
Interest Cover-24.9
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.87$
Cash pS0.00$
Book-Value pS0.71$
Tangible Book-Value pS0.83$
Cash Flow pS-1.08$
Free Cash Flow pS-1.08$
KEY FIGURES (LTM): Price info
Price/Book Ratio1.17
Price/Tangible Book Ratio0.00
Price/Cash Flow
Price/Free Cash Flow
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----5.5169,306620,827
4 Weeks0.960.730.88-16.5210,3133,995,959
13 Weeks3.080.691.96-62.7985,95562,115,175
26 Weeks3.080.691.71-57.2846,135104,920,802
52 Weeks6.740.694.47-83.6745,043186,260,774
YTD3.080.69--59.6804,51986,888,152
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
0.770.800.931.912.790.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.0
Income0.0
Dividend0.0
Capital SpendingNA
R&DNA
Normalized Inc.NA
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %
Earnings %
EPS %
EPS $
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio59.23
Current Ratio2.6
Quick Ratio (Acid Test)2.4
Liquidity Ratio (Cash)2.82
Receivables Turnover9.5
Average Collection Period38
Working Capital/Equity105.5
Working Capital pS0.87
Cash-Flow pS-1.15
Free Cash-Flow pS-1.15
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio-0.28
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio0.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities0.0
Interest Cover-24.9
Interest/Capital Invested2.54
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.57
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA1.43
Enterprise Value (EV)/Free Cash Flow-0.26
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM1.17
Price/Cash Flow Ratio
Price/Free Cash Flow Ratio - LTM
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM
P/E Ratio (26 weeks ago) - LTM
P/E Ratio (52 weeks ago) - LTM
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS0.65
Tangible Book Value pS - LTM0.83
Book Value pS - LTM0.71
Capital Invested pS0.83
Cash pS - LTM0.00
Cash Flow pS - LTM-1.08
Free Cash Flow pS - LTM-1.08
Earnings pS (EPS)-0.59
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-103.98
Free Cash Flow Margin 5YEAR AVG633.40
Net Profit Margin-0.5
Net Profit Margin - 5YEAR AVRG.
Equity Productivity1.23
Return on Equity (ROE)-0.7
Return on Equity (ROE) - 5YEAR AVRG.-0.7
Capital Invested Productivity1.23
Return on Capital Invested (ROCI)-0.7
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.7
Assets Productivity0.50
Return on Assets (ROA)-0.3
Return on Assets (ROA) - 5YEAR AVRG.-0.4
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.
EBITDA Margin - LTM-51.3
EBIT Margin - LTM-51.6
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee1,083,419
Net Income per Employee
Average Collection Period
Receivables Turnover9.5
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.0
Accounts Payble/Sales18.51
Assets/Revenue2.00
Net Working Capital Turnover1.16
Fixed Assets Turnover24.39
Total Assets Turnover0.5
Revenue per $ Cash2.90
Revenue per $ Plant218.09
Revenue per $ Common Equity1.23
Revenue per $ Capital Invested1.23
Selling, General & Adm/tive (SG&A) as % of Revenue31.2
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue123.2
R&D Expense as % of Revenue - 5YEAR AVRG.123.2

  
Your Recent History
NASDAQ
CNAT
CONATUS PH..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190717 18:25:19